-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.INR↓
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von
Dir gefallen die Informationen zu Aurobindo Pharma?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Aurobindo Pharma?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Aurobindo Pharma?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Aurobindo Pharma?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
29 News & Informationen zur Aurobindo Pharma Aktie
Aurobindo Pharma share price: Aurobindo Pharma stock price down 2.14 per cent as Sensex slides
As of 30-Jun-2021, promoters held 48.76 per cent stake in the company, while FIIs held 23.7 per cent and domestic institutional investors had 9.03 per cent.
Stock market update: Nifty Pharma index falls 0.59% in an upbeat market
The Nifty Pharma index was trading 0.59 per cent down at 14431.75.
Trade setup for Monday: Top 15 things to know before Opening Bell
Shrikant Chouhan of Kotak Securities feels the 16,150-16,050 level would be the strong support zone for the index.
Dalal Street Week Ahead | 10 key factors that will keep traders busy next week
As per Ajit Mishra of Religare Broking, the broader market may underperform in near future. Investors should focus on index majors and other heavyweights and maintain extra caution while selecting stocks from the mid and small-cap space.
Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
The Hyderabad-based drug major is looking to develop products with higher complexity, focus on injectables business and expand business in high growth markets like China.
Aurobindo Pharma share price: Aurobindo Pharma shares up 0.32% as Nifty gains
A total of 31,952 shares changed hands on the counter till 12:09PM (IST).
Healthcare funds that weathered the industry’s cyclicality
Funds managed by UTI, SBI and Nippon offer time-tested performance
Nifty Pharma tanks 4.33%, records worst intra-day fall since December; Dr Reddy’s plummets 10%
Nifty Pharma index came under attack from bears on Tuesday forcing the sectoral gauge to close 4.33% lower, the worst single-day fall recorded by the index since December last year.
Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months
Read more about Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months on Business Standard. Alembic Pharma and Dr Reddy's Labs plunged 12% and 11%, respectively in intra-day trade post their June quarter results
Glenmark Life Sciences IPO opens today, should you subscribe?
Glenmark Life Sciences IPO: The company has debt-to-equity of 1.3x with a debt of Rs 916 crore which includes Rs 800 crore payable to Glenmark Pharmaceuticals, post-IPO debt will be negligible.
IPO-bound Glenmark Life Sciences to focus on complex bulk drugs, contract business to drive growth
The company plans to develop eight to 10 molecules each year including high-value and high-volume APIs. It is looking at participating in the government’s production-linked incentive scheme.
Aurobindo Pharma share price: Aurobindo Pharma declines 0.76% as Sensex slides
The stock traded at a P/E multiple of 10.51, while the price-to-book value ratio stood at 1.44.
Stock market update: Nifty Pharma index advances 0.15%
The Nifty Pharma index closed 0.15 per cent up at 14597.85.
Aurobindo Pharma share price: Aurobindo Pharma shares up 0.34% as Nifty gains
A total of 16,552 shares changed hands on the counter till 01:30PM (IST).
Stock market update: Nifty Pharma index falls 1.3%
The Nifty Pharma index closed 1.3 per cent down at 14479.2.
Aurobindo Pharma share price: Aurobindo Pharma shares rise 0.21% as Nifty drops
The stock quoted a 52-week high price of Rs 1063.75 and a 52-week low of Rs 737.9.
Gainers & Losers: 10 stocks that moved most on July 16
Among the sectors, Nifty pharma, realty and metal indices rose over a percent each, while Nifty IT fell over a percent
Aurobindo Pharma share price: Share price of Aurobindo Pharma falls as Sensex gains 14.9 points
A total of 150,179 shares changed hands on the counter till 01:27PM (IST)
ETMarkets Morning Podcast: 30 hidden gems than can still offer 30%
Tune in as we tell you what's happening in the market, what's making news this morning, and look at some of the buzzing stocks.
Indices end with minor losses in a lacklustre week; smallcaps outperform
The fear of the third wave of coronavirus and the rising cases of delta plus variant kept bulls on the sidelines in the week gone by, but the losses were capped amid unlocking of the economy.
Top Pharma Mutual Funds To Start SIP In India 2021 For Long Term Capital Appreciation
As of 2021, the market of pharma industry as per the Indian Economy Survey is estimated at US$ 42 billion in 2021 and expected to scale to US$65 billion by 2024 and further scale to US$120-130 billion by 2030.Amid all such endeavours and the recent aggressiveness the sector is witnessing due to Covid 19 vaccine push etc., it will not be wrong to bet on Indian pharma growth story.
Sensex, Nifty Recover After Fall From Higher Levels
(RTTNews) – After opening on a positive note, the Indian stock market slipped into negative territory in cautious trade Friday morning. Uncertain…
Aurobindo Pharma to transfer biz in Unit-4 to arm Eugia Pharma; stock up 4%
Read more about Aurobindo Pharma to transfer biz in Unit-4 to arm Eugia Pharma; stock up 4% on Business Standard. The company said the transfer of the business undertaking will be done for a lumpsum consideration of Rs 876 crore
Ahead of Market: 12 things that will decide stock action on Friday
The headline index Nifty moved in a range of 88 points and fell below the crucial 15,700 level to form a bearish candle on the daily chart.
Aurobindo Pharma share price: Share price of Aurobindo Pharma jumps as Sensex drops 120.04 points
Promoters held 48.86 per cent stake in the company as of 31-Mar-2021, while FII and DII ownership stood at 24.37 per cent and 8.84 per cent, respectively.
Aurobindo Pharma share price: Aurobindo Pharma shares up 0.92% as Nifty drops
A total of 50,916 shares changed hands on the counter till 12:09PM (IST).
Aurobindo Pharma share price: Aurobindo Pharma shares gain 1.32% as Sensex rises
The stock quoted a 52-week high of Rs 1063.75 and a 52-week low of Rs 737.9.
Experts advise caution at higher levels, pick 10 names ahead of June F&O expiry based on technical analysis
As far as levels are concerned, 15,820 – 15,880 are immediate resistances, whereas 15,550 – 15,450 – 15,400 are support levels, suggest experts.
15400 a decisive support for Nifty; stay selective and stick to quality in small & midcaps: Mehul Kothari of AnandRathi
Kothari is bullish on UBL, Sun Pharma and Aurobindo Pharma for the short term